105 related articles for article (PubMed ID: 24533562)
1. Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios.
Mojzikova R; Koralkova P; Holub D; Zidova Z; Pospisilova D; Cermak J; Striezencova Laluhova Z; Indrak K; Sukova M; Partschova M; Kucerova J; Horvathova M; Divoky V
Br J Haematol; 2014 May; 165(4):556-63. PubMed ID: 24533562
[TBL] [Abstract][Full Text] [Related]
2. PKLR mutations in pyruvate kinase deficient Polish patients: Functional characteristics of c.101-1G > A and c.1058delAAG variants.
Maciak K; Jurkiewicz A; Strojny W; Adamowicz-Salach A; Romiszewska M; Jackowska T; Kwiecinska K; Poznanski J; Gora M; Burzynska B
Blood Cells Mol Dis; 2024 Jul; 107():102841. PubMed ID: 38581917
[TBL] [Abstract][Full Text] [Related]
3. Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency.
van Beers EJ; Al-Samkari H; Grace RF; Barcellini W; Glenthøj A; DiBacco M; Wind-Rotolo M; Xu R; Beynon V; Patel P; Porter JB; Kuo KHM
Blood Adv; 2024 May; 8(10):2433-2441. PubMed ID: 38330179
[TBL] [Abstract][Full Text] [Related]
4. Updates and advances in pyruvate kinase deficiency.
Luke N; Hillier K; Al-Samkari H; Grace RF
Trends Mol Med; 2023 May; 29(5):406-418. PubMed ID: 36935283
[TBL] [Abstract][Full Text] [Related]
5. Consensus document for the diagnosis and treatment of pyruvate kinase deficiency.
Morado M; Villegas AM; de la Iglesia S; Martínez-Nieto J; Del Orbe Barreto R; Beneitez D; Salido E;
Med Clin (Barc); 2021 Sep; 157(5):253.e1-253.e8. PubMed ID: 33431182
[TBL] [Abstract][Full Text] [Related]
6. Neonatal Thrombocytopenia as a Presenting Finding in de novo Pyruvate Kinase Deficiency.
Dulmovits BM; Wild KT; Flibotte J; Lambert MP; Kwiatkowski J; Thom CS
Neonatology; 2023; 120(5):661-665. PubMed ID: 37473739
[TBL] [Abstract][Full Text] [Related]
7. Anemia in the Neonate: The Differential Diagnosis and Treatment.
Nassin ML; Lapping-Carr G; de Jong JL
Pediatr Ann; 2015 Jul; 44(7):e159-63. PubMed ID: 26171704
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of pyruvate kinase deficiency: A systematic literature review.
Secrest MH; Storm M; Carrington C; Casso D; Gilroy K; Pladson L; Boscoe AN
Eur J Haematol; 2020 Aug; 105(2):173-184. PubMed ID: 32279356
[TBL] [Abstract][Full Text] [Related]
9. Mitapivat: A Review in Pyruvate Kinase Deficiency in Adults.
Zhuang-Yan A; Shirley M
Drugs; 2023 Nov; 83(17):1613-1620. PubMed ID: 37991635
[TBL] [Abstract][Full Text] [Related]
10. Erythrocytic pyruvate kinase mutations causing hemolytic anemia, osteosclerosis, and secondary hemochromatosis in dogs.
Gultekin GI; Raj K; Foureman P; Lehman S; Manhart K; Abdulmalik O; Giger U
J Vet Intern Med; 2012; 26(4):935-44. PubMed ID: 22805166
[TBL] [Abstract][Full Text] [Related]
11. Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders.
Xu Y; Alfaro-Magallanes VM; Babitt JL
Br J Haematol; 2021 Jun; 193(5):882-893. PubMed ID: 33316086
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease.
Parekh DS; Eaton WA; Thein SL
Blood; 2024 Mar; 143(10):866-871. PubMed ID: 38118071
[TBL] [Abstract][Full Text] [Related]
13. Pyruvate kinase activators for treatment of pyruvate kinase deficiency.
Grace RF
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):97-106. PubMed ID: 38066940
[TBL] [Abstract][Full Text] [Related]
14. Isolated ACTH deficiency: an uncommon cause of hyperferritinaemia.
Isoda A; Saito A; Matsumoto M; Sawamura M
BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37816574
[TBL] [Abstract][Full Text] [Related]
15. Genetic Diagnosis of Pyruvate Kinase Deficiency in Undiagnosed Iranian Patients with Severe Hemolytic Anemia, using Whole Exome Sequencing.
Mehrabi Sisakht J; Mehri M; Najmabadi H; Azarkeivan A; Neishabury M
Arch Iran Med; 2022 Oct; 25(10):691-697. PubMed ID: 37542401
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome and genotype analysis of four Chinese children with pyruvate kinase deficiency.
Xie F; Gan L; Lei L; Cai T; Gao Y; Liu X; Cai B; Zhou L
Mol Genet Genomic Med; 2023 Nov; 11(11):e2239. PubMed ID: 37466302
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in adult patients with pyruvate kinase deficiency on long-term mitapivat treatment.
Al-Samkari H; Grace RF; Glenthøj A; Andres O; Barcellini W; Galacteros F; Kuo KHM; Layton DM; Morado M; Viprakasit V; Tai F; Urbstonaitis R; Morales J; McGee B; Beers EJV
Haematologica; 2024 Mar; 109(3):963-967. PubMed ID: 37731369
[No Abstract] [Full Text] [Related]
18. Acquired pseudoxanthoma elasticum-like syndrome and pyruvate kinase deficiency: a case of iron overload?
Robert M; Audebert S; Eveillard JR; Galacteros F; El Aridi L; Glen LF; Billon C; Misery L; Abasq-Thomas C
Eur J Dermatol; 2023 Jun; 33(3):319-320. PubMed ID: 37594352
[No Abstract] [Full Text] [Related]
19. Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency.
Zagadailov E; Al-Samkari H; Boscoe AN; McGee B; Shi S; Macaulay D; Shi L; Garcia-Horton V
Hematology; 2024 Dec; 29(1):2290746. PubMed ID: 38095306
[TBL] [Abstract][Full Text] [Related]
20. Novel
Fawaz N; Beshlawi I; Alqasim A; Zachariah M; Russo R; Andolfo I; Gambale A; Pathare A; Iolascon A
Clin Case Rep; 2022 Feb; 10(2):e05315. PubMed ID: 35154711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
